Small animal imaging market to surpass $3B by 2026
by Katie Pfaff
The global market for small animal imaging (in-vivo) market is expected to reach $3.38 billion by 2026, according to a report by ReportLinker, an award-winning market research company.
According to a news release, the market is expected to grow from just over $2 billion in 2021 to $2.27 billion in 2022 at a compound annual growth rate (CAGR) of 10.4%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term.
The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices and supply chain disruptions, affecting many markets across the globe.
Between 2021 and 2022, the market is estimated to grow at a CAGR of 10.4%. While during the years 2022 and 2026, the market is forecasted to grow at a CAGR of 10.5%.
Growth in the market is expected as animal healthcare spending continues to increase. At the same time, technological advances have added to growth and increased the standing of innovative companies.
In 2021, North America was the largest region in the market while Europe is expected to be the fastest-growing region across the period.
Major players in the market include Bruker, PerkinElmer, Miltenyi Biotec, Aspect Imaging Ltd, Mediso Ltd, LI-COR Biosciences, Life Technologies Corporation, Trifoil Imaging, Promega Corporation, New England Biolabs, MR Solutions Ltd, General Electric, Sofie Biosciences Inc, Biospace Lab and Agilent Technologies Inc.
Read the full report: https://www.reportlinker.com/p06364862/?utm_source=PRN
Comments
Related Articles
Copyright © 2025 - All Rights Reserved
ISSN 2768-198X
List
Add
Please enter a comment